These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 18219220

  • 1. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H, Takahashi Y, Iida K, Kudo T, Nishizawa H, Imanaka M, Takeno R, Iguchi G, Takahashi K, Okimura Y, Kaji H, Chihara K.
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [Abstract] [Full Text] [Related]

  • 2. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

  • 3. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ, Jia WP, Zhu M, Lu JX, Chen L, Xiang KS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1781-4. PubMed ID: 15631773
    [Abstract] [Full Text] [Related]

  • 4. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L, Fu X, Xu L, Zheng S, Zhou W, Wang X, Gu Y, Lin F, Luo M.
    Clin Endocrinol (Oxf); 2008 Oct 02; 69(4):575-9. PubMed ID: 18248638
    [Abstract] [Full Text] [Related]

  • 5. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O, Beauregard C, Hardy J.
    J Clin Endocrinol Metab; 2004 Feb 02; 89(2):658-61. PubMed ID: 14764777
    [Abstract] [Full Text] [Related]

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 02; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 7. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN, Comninos AN, Clarke H, Donaldson M, Meeran K, Dhillo WS.
    Clin Endocrinol (Oxf); 2011 Aug 02; 75(2):220-5. PubMed ID: 21521288
    [Abstract] [Full Text] [Related]

  • 8. Homocysteine levels in acromegaly patients.
    Hekimsoy Z, Ozmen B, Ulusoy S.
    Neuro Endocrinol Lett; 2005 Dec 02; 26(6):811-4. PubMed ID: 16380700
    [Abstract] [Full Text] [Related]

  • 9. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 10. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
    Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A.
    Clin Endocrinol (Oxf); 2004 Jul 20; 61(1):138-44. PubMed ID: 15212656
    [Abstract] [Full Text] [Related]

  • 11. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P, Saraç F, Saygili F, Ozgen AG, Yilmaz C, Tüzün M.
    Acta Diabetol; 2008 Sep 20; 45(3):151-6. PubMed ID: 18496644
    [Abstract] [Full Text] [Related]

  • 12. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, Cappabianca P, Lombardi G.
    Clin Endocrinol (Oxf); 2006 Aug 20; 65(2):250-6. PubMed ID: 16886969
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC, Miranda WL, Chacra AR, Dib SA.
    J Diabetes Complications; 2007 Aug 20; 21(2):84-92. PubMed ID: 17331856
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S, Abrahami M, Lilos P, Phillip M.
    Int J Obes (Lond); 2005 Jun 20; 29(6):571-8. PubMed ID: 15889115
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.
    Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D.
    Pituitary; 2014 Feb 20; 17(1):81-9. PubMed ID: 23446424
    [Abstract] [Full Text] [Related]

  • 16. [Arterial hypertension in obese patients with heart hypertrophy. Effects of captopril on insulin sensitivity and growth hormone].
    Velasco-Cornejo IF, Martin LC, Brandão-Neto J, Marchioli M, de Barros e Silva M, Anthanázio-Heliodoro Rde C, Franco RJ da S.
    Arq Bras Cardiol; 1995 Feb 20; 64(2):125-32. PubMed ID: 7575157
    [Abstract] [Full Text] [Related]

  • 17. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G, Koltai MS, Ademaj F, Rexhepaj N, Qirko S, Ndrepepa G, Elezi S.
    Int J Cardiol; 2006 Jun 16; 110(2):206-11. PubMed ID: 16297997
    [Abstract] [Full Text] [Related]

  • 18. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC.
    Horm Metab Res; 2010 Jan 16; 42(1):50-5. PubMed ID: 19798623
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of suppression of growth hormone levels following a 75g oral glucose tolerance test.
    Nazaimoon WM, Ng ML, Satgunasingam N, Khalid BA.
    Med J Malaysia; 1992 Jun 16; 47(2):103-9. PubMed ID: 1494329
    [Abstract] [Full Text] [Related]

  • 20. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.
    Obes Res; 2002 Aug 16; 10(8):717-25. PubMed ID: 12181379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.